TC
ABBV icon

TFS Capital’s AbbVie ABBV Stock Holding History

TFS Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,802
Closed -$421K – 2
2017
Q2 		$421K Buy
+5,802
New +$390K 0.17% 243
2017
Q1 		– Sell
-8,355
Closed -$523K – 640
2016
Q4 		$523K Buy
8,355
+2,271
+37% +$139K 0.14% 207
2016
Q3 		$384K Buy
+6,084
New +$394K 0.09% 352

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

TFS Capital's ABBV Position: Q3 2017 in Review

TFS Capital sold out of AbbVie (ABBV) in Q3 2017, closing a stake of 5,802 shares — an estimated $421K sold.

TFS Capital first reported a position in ABBV in Q3 2016 and held it in 3 quarters. The position peaked at $523K in Q4 2016. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

  • TFS Capital reported no remaining AbbVie position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 5,802 AbbVie shares in Q3 2017, an estimated $421K.
  • TFS Capital first reported a position in AbbVie in Q3 2016 and held it in 3 quarters.
  • TFS Capital's AbbVie position peaked at $523K in Q4 2016.
  • 1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.